Our Portfolio


Featured Projects

A Liquid Biopsy Test for the Early Detection of High-Risk Colorectal Adenomas

ASPIRE Award (2020-Present)

Dan Landau, MD, PhD, Weill Cornell School of Medicine (Principal) and Claus Andersen, PhD, Aarhus University

Read More

A Model System for Robust Identification of Neoantigen-Specific T-cell Receptors

ASPIRE AWARD (2018-2020; 2020-PRESENT)

Michelle Krogsgaard, PhD (Principal); Jef Boeke, PhD; and Jeffrey Weber, MD, PhD, New York University

Read More

Tumor-Specific Immunotherapy for a Rare Pediatric Liver Cancer

ASPIRE Award (2020-Present)

Paul Thomas, PhD, St. Jude Children’s Research Hospital

Read More

Exploiting Lymphatic Transport for Early Detection

2020 Emerging Leader Award

Amanda Lund, PhD, New York University

Read More


All Projects

filter by

Program

Research Area

Cancer Types

Show All

Elucidating the Mechanism of Menin-MLL Interaction Inhibition in NPM1c Mutated Acute Myeloid Leukemia

Momentum Fellow (2020-Present)

Hannah Uckelmann, PhD, Dana-Farber Cancer Institute

Read More

Loss of the Non-Canonical BAF Complex as a Driver and Therapeutic Target in SF3B1-Mutant MDS and Leukemia

IN PARTNERSHIP WITH LEUKEMIA & LYMPHOMA SOCIETY AND THE PAUL G. ALLEN FRONTIERS GROUP (2020-PRESENT)

Robert Bradley, PhD, Fred Hutchinson Cancer Research Center

Read More

Targeting Leukemia Stem Cells by Disrupting Translational Fidelity

IN PARTNERSHIP WITH LEUKEMIA & LYMPHOMA SOCIETY AND THE PAUL G. ALLEN FRONTIERS GROUP (2020-PRESENT)

Robert Signer, PhD, University of California San Diego

Read More

Clonal Evolution of Pre-Leukemic Hematopoietic Stem Cells in Human Myeloid Malignancies

IN PARTNERSHIP WITH LEUKEMIA & LYMPHOMA SOCIETY AND THE PAUL G. ALLEN FRONTIERS GROUP (2020-PRESENT)

Ravi Majeti, MD, PhD, Stanford University School of Medicine

Read More

Development and Application of a Pan-Cancer Diagnostic Test for Early Detection of Cancer

Momentum Fellow (2020-Present)

Dimitrios Mathios MD, Johns Hopkins University School of Medicine

Read More

Mechanisms of Tumor-Initiation in B-Lymphoid Malignancies

IN PARTNERSHIP WITH LEUKEMIA & LYMPHOMA SOCIETY AND THE PAUL G. ALLEN FRONTIERS GROUP (2020-PRESENT)

Markus Müschen, MD, PhD, City of Hope

Read More

Characterizing a Novel RasGRP1-mTOR Pathway in Immune and Cancer Cells

Momentum Fellow (2020-Present)

Kriti Bahl, PhD, University of California, San Francisco

Read More

In Vivo Generation of Chimeric Antigen Receptor Cells to Treat Hemopoietic Malignancies

IN PARTNERSHIP WITH LEUKEMIA & LYMPHOMA SOCIETY AND THE PAUL G. ALLEN FRONTIERS GROUP (2020-PRESENT)

Ron Levy, MD, Stanford University School of Medicine

Read More

Dissecting Tumor Intrinsic and Immune Drivers of Resistance to Therapy in Non-Small Cell Lung Cancer

Damon Runyon - Mark Foundation Physician-Scientist (2020-Present)

Natalie Vokes, MD, Dana-Farber Cancer Institute

Read More

Statistical Approaches for Earlier Detection of Cancer

Momentum Fellow (2020-Present)

Stephen Cristiano, PhD, Johns Hopkins University School of Medicine

Read More